TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 SEK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
115,781
|
96,974
|
87,854 |
| Financial expenses |
30
|
0
|
0 |
| Earnings before taxes |
9,407
|
13,294
|
12,611 |
| EBITDA |
9,478
|
13,370
|
12,774 |
| Total assets |
49,580
|
36,839
|
42,719 |
| Current assets |
49,401
|
36,684
|
42,503 |
| Current liabilities |
18,718
|
13,472
|
10,116 |
| Equity capital |
27,740
|
20,344
|
29,928 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
55.9%
|
55.2%
|
70.1% |
| Turnover per employee |
11,578
|
9,697
|
8,785 |
| Profit as a percentage of turnover |
8.1%
|
13.7%
|
14.4% |
| Return on assets (ROA) |
19.0%
|
36.1%
|
29.5% |
| Current ratio |
263.9%
|
272.3%
|
420.2% |
| Return on equity (ROE) |
33.9%
|
65.3%
|
42.1% |
| Change turnover |
18,807
|
9,120
|
4,601 |
| Change turnover % |
19%
|
10%
|
6% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.